Thursday, October 24, 2019
Screening and Treatment for Iron Deficiency in HFrEF with Ferric Carboxymaltose
Clinical practice update on heart failure 2019:pharmacotherapy, procedures, devices andpatient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology Petar M. Seferovic1, Piotr Ponikowski2, Stefan D. Anker3*, Johann Bauersachs4, Ovidiu Chioncel5, John G.F. Cleland6, Rudolf A. de Boer7, Heinz Drexel8, Tuvia Ben Gal9, Loreena Hill10, Tiny Jaarsma11, Ewa A. Jankowska2, Markus S. Anker12, Mitja Lainscak13, Basil S. Lewis14, Theresa McDonagh15, Marco Metra16, Davor Milicic17, Wilfried Mullens18, Massimo F. Piepoli19, Giuseppe Rosano20, Frank Ruschitzka21, Maurizio Volterrani22, Adriaan A. Voors7, Gerasimos Filippatos23, and Andrew J.S. Coats24*
Ferric Carboxymaltose
Subscribe to:
Post Comments (Atom)
-
I will write more about this in the next blog, but the concept of driving pressure ( Pdr = Vt/Crs- Vt; tidal volume, Crs; compliance respir...
-
CV Medications in Pregnancy Table for Quick Review, I posted this article earlier in the year but not the Central Illustration Cardiova... -
The following are key points to remember from this Expert Consensus Document on the Fourth Universal Definition of Myocardial Infarction (M...
No comments:
Post a Comment